LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi announced today the immediate availability in the United States of Atropine Sulfate Injection, USP in an 8 mg per 20 mL presentation. Fresenius Kabi ...
Atropine is a muscarinic antagonist and is indicated for temporary blockage of severe or life threatening muscarinic effects. Atropine Sulfate Injection is now available in an 8mg per 20mL ...
MELVILLE, N.Y., Aug. 9, 2022 /PRNewswire/ -- American Regent, Inc. has announced the launch of Atropine Sulfate Injection, USP, a longstanding injectable medication, now with FDA approval. Atropine ...
RANCHO CUCAMONGA, Calif., Oct. 06, 2020 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced that the U.S. Food and Drug Administration (“FDA”) approved the Company’s ...
GLENDALE HEIGHTS, Ill.--(BUSINESS WIRE)--Medefil, Inc., a domestic manufacturer of injectable products, has announced availability of its FDA-approved ANDA products, Atropine Sulfate Injection, USP, 1 ...
Atropine has long been used to treat abnormally slow heart rate in emergency situations by altering the way electrical signals move through the heart. Bradycardia is an especially slow heartbeat and a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback